Literature DB >> 2963621

Heterogeneity of D2 dopamine receptors in different brain regions.

M N Leonard1, C A Macey, P G Strange.   

Abstract

The binding of [3H]spiperone has been examined in membranes derived from different regions of bovine brain. In caudate nucleus, nucleus accumbens, olfactory tubercle and putamen binding is to D2 dopamine and 5HT2 serotonin receptors, whereas in cingulate cortex only serotonin 5HT2 receptor binding can be detected. D2 dopamine receptors were examined in detail in caudate nucleus, olfactory tubercle and putamen using [3H]spiperone binding in the presence of 0.3 microM-mianserin (to block 5HT2 serotonin receptors). No evidence for heterogeneity among D2 dopamine receptors either between brain regions or within a brain region was found from the displacements of [3H]spiperone binding by a range of antagonists, including dibenzazepines and substituted benzamides. Regulation of agonist binding by guanine nucleotides did, however, differ between regions. In caudate nucleus a population of agonist binding sites appeared resistant to guanine nucleotide regulation, whereas this was not the case in olfactory tubercle and putamen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963621      PMCID: PMC1148583          DOI: 10.1042/bj2480595

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Neuroleptic antagonism of dyskinetic phenomena.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1975 Sep-Oct       Impact factor: 4.432

3.  Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-09       Impact factor: 4.436

4.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

Authors:  J E Leysen; W Gommeren; P M Laduron
Journal:  Biochem Pharmacol       Date:  1978-02-01       Impact factor: 5.858

5.  Thioridazine is not specific for limbic dopamine receptors.

Authors:  G P Reynolds; L Cowey; M N Rossor; L L Iversen
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

6.  Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

Authors:  D R Sibley; A De Lean; I Creese
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

7.  3H-Domperidone: a selective ligand for dopamine receptors.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

8.  Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.

Authors:  S Lazareno; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1982-07-09       Impact factor: 4.432

9.  Pharmacological evidence for the subclassification of central dopamine receptors in the rat.

Authors:  A J Gower; A S Marriott
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

10.  Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.

Authors:  R M Withy; R J Mayer; P G Strange
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

View more
  4 in total

1.  Coupling of D2 dopamine receptors to G-proteins in solubilized preparations of bovine caudate nucleus.

Authors:  J A Chazot; P G Strange
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

2.  Importance of thiol groups in ligand binding to D2 dopamine receptors from brain and anterior pituitary gland.

Authors:  P L Chazot; P G Strange
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

3.  The glycosylation properties of D2 dopamine receptors from striatal and limbic areas of bovine brain.

Authors:  M N Leonard; R A Williamson; P G Strange
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

4.  Purification of brain D2 dopamine receptor.

Authors:  R A Williamson; S Worrall; P L Chazot; P G Strange
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.